Adrian Devitt-Lee, Project CBD’s chief science writer, is the winner of the Norbert Wiener Award in Mathematics from Tufts University, where he graduated with a MS in Math and a BA in Chemistry. He is the co-author of several articles in peer-reviewed publications, including the Journal of Physiology, F1000Research, SIAM Journal on Applied Mathematics, and Physica A. Devitt-Lee’s report on cannabinoid-pharmaceutical interactions was published in Sonoma Medicine. As a R&D intern with Medicinal Genomics, he identified mutations in the CBDA synthase gene in plant varieties. He also performed cell culture, time-lapse microscopy, flow cytometry and RNA extraction on cancer cells as an intern with the California Pacific Medical Center in San Francisco. As a senior research associate with CannaCraft, Inc., Devitt-Lee researched pesticide and solvent safety and provided regulatory input to California government officials. He is currently a chemistry researcher at the University College in London.
“[T]he degree of impairment resulting from recent cannabis use is difficult to distinguish from other conditions such as advancing age or use of certain medications,” according to a review in The American Journal of Drug and Alcohol Abuse. It begs the question of why cannabis should be treated differently.